Ya Tian, Zixin Fan, Xianlu Zeng, Zhen Yu, Xiaofeng Lu, Xinyu Zhao, Zhenquan Wu, Honghui He, Jian Zeng, Lei Zheng, Linlin Zhang, Victor S M C Correa, Guishuang Ying, Shaochong Zhang, Guoming Zhang
PURPOSE: To evaluate the long-term cognitive function in children treated with intravitreal ranibizumab (IVR) for retinopathy of prematurity(ROP), and the impact of IVR on the growth and ocular development. METHODS: In this retrospective study, the premature children aged 4 to 9 years who received monotherapy of IVR (IVR group, n = 25) or monotherapy of laser photocoagulation (LP) (LP group, n = 33) for ROP, and the same age premature children with no ROP (Control group, n = 26) were enrolled from 2020 to 2022 in the pediatric fundus clinic of Shenzhen Eye Hospital...
April 21, 2024: Graefe's Archive for Clinical and Experimental Ophthalmology